Skip to main content
. 2023 Jan 19;80(2):46. doi: 10.1007/s00018-023-04694-y

Fig. 4.

Fig. 4

H2O2 responsive nature of nanoceria exploited for tumour-selected drug delivery. a Working principle of CeO2@MSNs@IR780/Met NPs that were synthesized by loading photosensitiser IR780 and mitochondrial respiration inhibitor Metformin into mesoporous silica nanoparticles MSNs with CeO2 as the gatekeepers. IR780 and Met were released, while O2 and Ce2+ were generated after the etching of CeO2 NPs in response to the special tumour microenvironment with lower pH and excessive H2O2. b, c In vitro release behaviour detection: b Time-dependant release performance of IR780 (red column) and Met (black column) from the CeO2@MSNs@IR780/Met NPs in the absence and presence of 1.0 and 2.0 M H2O2. c Etching performance of Ce NPs. Ce ions detected by inductively coupled plasma (ICP) analysis under various conditions: control, 10–20 mM H2O2, and nitric acid. d TEM image of the CeO2@MSNs@IR780/Me nanocomposition in 20 mM H2O2 solution after 6 h. Reprinted with permission from [32].

Copyright 2020 American Chemical Society